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Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
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Stem cell–based regenerative therapy is a promising treatment for head and neck cancer patients that suffer from chronic
dry mouth (xerostomia) due to salivary gland injury from radiation therapy. Current xerostomia therapies only provide
temporary symptom relief, while permanent restoration of salivary function is not currently feasible. Here, we identified
and characterized a stem cell population from adult murine submandibular glands. Of the different cells isolated from
the submandibular gland, this specific population, Lin–CD24+c-Kit+Sca1+, possessed the highest capacity for proliferation,
self renewal, and differentiation during serial passage in vitro. Serial transplantations of this stem cell population into the
submandibular gland of irradiated mice successfully restored saliva secretion and increased the number of functional acini.
Gene-expression analysis revealed that glial cell line–derived neurotrophic factor (Gdnf) is highly expressed in Lin–CD24+
c-Kit+Sca1+ stem cells. Furthermore, GDNF expression was upregulated upon radiation therapy in submandibular glands of
both mice and humans. Administration of GDNF improved saliva production and enriched the number of functional acini
in submandibular glands of irradiated animals and enhanced salisphere formation in cultured salivary stem cells, but did
not accelerate growth of head and neck cancer cells. These data indicate that modulation of the GDNF pathway may have
potential therapeutic benefit for management of radiation-induced xerostomia.

Introduction

Xerostomia is the condition of severe hyposalivation resulting
from damage of salivary glands from medications, systemic diseases (such as diabetes and Sjögren syndrome), and radiotherapy
(RT) for head and neck cancer (HNC). More than 30,000 people
in the United States are diagnosed with HNC annually (1); most
of these patients receive RT as part of their treatment (2). Despite
the widespread application of intensity-modulated RT (IMRT) to
spare the parotid glands during HNC treatment, submandibular
glands (SMG) are often damaged due to their proximity to the
regional nodes, which are often involved in HNC. Consequently,
over 80% of HNC patients treated with RT suffer from xerostomia, which severely impairs their quality of life (3). Current treatment options for RT-related xerostomia are limited and mainly
focus on temporary symptom improvement (4). Stem cell (SC)
therapy, in contrast, offers the possibility of permanently restoring
function of the damaged glands and is therefore more attractive
than existing therapeutic strategies.
The first cell-surface marker used to isolate putative salivary
SCs (SSCs) from murine (5) and human SMG (6) was c-Kit. Other
markers that have been used to identify SSCs include Sca1 (5, 7),
Thy-1 (8), integrin α6β1, (9, 10), and CD34 (11). The first in vivo
transplantation assay used murine c-Kit+ cells from SMG. When
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transplanted into irradiated recipient SMGs, c-Kit+ cells partially
restored the saliva secretion in these mice (5). One major drawback of using a single cell-surface marker for SSC identification
is the large heterogeneity within the isolated cell population due
to contamination by hematopoietic cells and nonstem epithelial
cells. Consequently, the purity of isolated SSCs, their optimal function, and their gene expression remain to be further elucidated.
By including a combination of cell-surface markers to select
primarily for epithelial SCs while excluding hematopoietic lineages, we were able to obtain a much purer population of SSCs
from adult mouse SMG. The Lin–CD24+c-Kit+Sca1+–enriched SSCs
formed the highest number of salispheres as well as the largest and
the most proliferative spheres in vitro. These cells were capable of
self renewal and differentiation in vitro. Moreover, transplantation
of as few as 200 to 300 Lin–CD24+c-Kit+Sca1+ cells into preirradiated SMG successfully enhanced saliva secretion and the number
of functional acini on serial transplantation studies in vivo.
Improving SC survival while maintaining their regenerative
properties during serial passaging in vitro and in vivo is a major
challenge in SC therapy (12). Therefore, it is important to further characterize SSCs and identify the critical pathways for their
survival and stemness. In this study, we also compared the gene
expression of the Lin–CD24+c-Kit+Sca1+ SSC–enriched population
to other subpopulations of SMG epithelial cells. We identified glial
cell line–derived neurotrophic factor (Gdnf) as a gene that is preferentially expressed at high level in SSCs.
GDNF is a member of the GFL family, which also includes
neurturin (NRTN), artemin (ARTN), and persephin (PSPN) (13,
14). GDNF has been known to play an important role in neuron

Downloaded from http://www.jci.org on June 15, 2017. https://doi.org/10.1172/JCI74096

The Journal of Clinical Investigation  

Research article

Figure 1. Identification of murine SMG SCs. (A) Flow chart of the SSC isolation strategy. FSC, forward scatter; SSC, side scatter; FSH, forward scatter
height; FSW, forward scatter width; SSH, side scatter height; SSW, side scatter width. (B) Representative sorting plot for SSCs. DAPI negative, single living
cells were first separated with epithelial marker CD24 and hematopoietic and endothelial lineage marker CD45/31. Lin–CD24hi (P5), Lin–CD24lo (P19), and
Lin–CD24– (P20) subpopulations were further separated with SC markers c-Kit and Sca1. (C) P7–P18 subpopulations were sorted and cultured on Matrigel.
Representative growth patterns at D14 in vitro. Scale bar: 100 μm. (D) Quantification of salisphere number to seeding-cell number of each population at D7
and D14 in vitro. *P < 0.05; **P < 0.01, 1-way ANOVA, compared with P10 Lin–CD24+c-Kit–Sca1– controls. n = 4. Data are presented as mean ± SEM.
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survival, growth, differentiation, and migration (13, 14). It also participates in renal morphogenesis and spermatogenesis by promoting SC self renewal and proliferation (15–17). In addition, GDNF
is currently being evaluated in the treatment of human Parkinson
disease in clinical trials, making it a promising candidate for future
SSC therapy (18, 19). We demonstrated that GDNF treatment in
vivo either before or after RT improved saliva production in irradiated SMGs without accelerating HNC growth. GDNF treatment
increased the number of surviving SCCs after RT in vivo and
enhanced salisphere formation in culture. GDNF expression in
SMG tissues increased with RT and colocalized with that of the
focal adhesion kinase (FAK) in SSCs. These data together suggest
that we have identified a highly enriched population of SSCs and
that GDNF signaling is important for SSC survival and could thus
be useful in future SC therapies.

Results
Isolation of an enriched population of murine SSCs
Defining the optimal combination of cell-surface markers for murine
SSC isolation. The steps for SSC enrichment are depicted in Figure 1A. After removing clumped cells, dead cells, and cell debris,
we depleted CD45+ and CD31+ hematopoietic and endothelial
lineage cells (20, 21). We then enriched for epithelial cells with
CD24 and EpCAM (CD326, a pan-epithelial marker) (22, 23).
Since all CD24+ cells were EpCAM+, we used CD24 as the epithelial selection marker in subsequent sorting (Supplemental Figure 1A; supplemental material available online with this article;
doi:10.1172/JCI74096DS1).
Because c-Kit is a well-known SC marker for many adult tissues (24, 25) and c-Kit+ cells have been shown to improve the function of irradiated murine SMGs (5), we used c-Kit as our anchor
SC selection marker. The second SC marker that we selected was
Sca1, which is an established hematopoietic SC marker (26) and
was used to identify SSCs in prior studies (5, 7).
We also evaluated CD49f (integrin α6, another putative marker for SSC and breast cancer SC) (8, 22, 27) and CD90.1 (Thy-1, a
hematopoietic stem marker) (28). Because all CD24+ cells were also
CD49f+ (Supplemental Figure 1B) and CD90.1+ cells did not improve
sphere formation over the CD24/c-Kit combination (Supplemental
Figure 1C), neither marker was used in subsequent sorting.
To evaluate the sphere-forming capacity of the different cell
subpopulations based on the 4 markers (CD24, c-Kit, Sca1, and lineage markers), we purified cells as depicted in Supplemental Table 1.
The percentage of each population relative to the parent population
is also shown in Supplemental Table 1. Representative flow profiles
are shown in Figure 1B. The highest percentage of c-Kit+Sca1+ cells
was noted in the CD24+ group (P8) (0.373%). Viable cells from 12
subpopulations of interest (P7–P18) were cultured in Matrigel. Several subpopulations were able to give rise to salispheres (Figure 1C).
The Lin–CD24+c-Kit+Sca1+ (P8) population yielded the highest salisphere number (Figure 1D); in contrast, Lin–CD24loc-Kit+Sca1+ (P16)
cells hardly formed any salisphere, indicating SSCs are derived
mainly from the CD24+ epithelial population.
In vitro characterization of SSCs. Lin–CD24+c-Kit+Sca1+ SSC–
enriched cells expressed higher levels of the SC and basal markers c-Kit, cytokeratin 5 (CK5), and CK14 compared with the Lin–
3366
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CD24+c-Kit– Sca1– cells (Supplemental Figure 2A). CK5 is a type II
cytokeratin that forms a heterotetramer with type I CK14. CK5 is
highly expressed in the embryonic SMG epithelial bud (29), while
CK14 is a marker of basal layer epidermis (30). In contrast, SSCs
expressed lower levels of acinar differentiation marker aquaporin 5 (AQP5) compared with control cells. AQP5, a water channel
protein that plays a major role in saliva production and secretion,
is only expressed in mature acinar cells (31). The mesenchymal
marker vimentin was expressed at the same level in both enriched
and nonenriched SSC populations (Supplemental Figure 2A).
Salispheres from Lin–CD24+c-Kit+Sca1+ SSC–enriched cells
actively proliferated for at least 14 days in vitro, as indicated by
Ki67 staining (Figure 2A). In addition, CK5 and CK14 partially
colocalized in day 7 (D7) and D14 salispheres (Figure 2B). These
results indicated that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells
expressed markers of basal layer epithelium and actively proliferated in vitro.
To show that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells could
differentiate in vitro, we stained the spheres for acinar marker
AQP5, ductal luminal epithelial marker CK8 (32), and ductal basal
epithelial marker CK14. AQP5 expression was patchy on D7 and D14
spheres and became more confluent on D21 spheres (Figure 2C).
A similar expression pattern was noted for amylase α, which is
a protein secreted by acinar cells (Figure 2D). CK8 and CK14
showed partial colocalization in D7 salispheres. CK8 was more
dominantly expressed in the sphere center at D21, while CK14 was
highly expressed in the sphere periphery (Figure 2E), a pattern
that mimics the expression of these 2 cytokeratins in adult SMG.
In contrast, the SC markers c-Kit, Sca1, and CK14 only partially
colocalized with the differentiation markers amylase α or AQP5 in
D21-cultured salispheres (Supplemental Figure 2B).
To prove the self-renewal ability of the SSCs in vitro, D7 salispheres were dissociated into single cells and recultured in Matrigel. They were able to form salispheres for at least 3 passages in
vitro. Salispheres from the third passage continued to express the
SC markers c-Kit and Sca1 up to D21 in culture (Figure 2F). MTT
assays indicated that SSC salispheres were actively growing at D14
in vitro (Supplemental Figure 2C). These findings showed that Lin–
CD24+c-Kit+Sca1+ SSC–enriched cells are capable of self-renewal,
proliferation, and differentiation in vitro.
SSC transplantation successfully rescues SMG function after
radiation. To prove that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells
could proliferate and differentiate in vivo, we injected SSCs isolated from male GFP mice directly into the SMG of the female
non-GFP recipients. The surface marker profile of SMG cells from
donor C57BL/6-Tg(UBC-GFP)30Scha/J mice showed a pattern
similar to that from C57BL/6 mice (Supplemental Figure 3A). The
GFP+ salisphere count derived from SSCs was also comparable to
that of C57BL/6 mice (Supplemental Figure 3, B and C). To test
whether the Lin–CD24+c-Kit+Sca1+ SSC–enriched cells can successfully rescue the function of SMG, the recipient mice received
15 Gy irradiation to the SMG before transplantation. As previously
reported, 15 Gy irradiation largely destroyed the acini in murine
SMGs (5, 11). As controls, Lin–CD24+c-Kit– Sca1– cells and unsorted
bulk SMG cells were transplanted into irradiated SMGs of 2 other
mouse cohorts. Stimulated saliva secretion was recorded over
time to evaluate SMG function (Figure 3A).
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Figure 2. SSCs form salispheres and proliferate and differentiate in vitro. (A) Sorted SSCs grew into salispheres in vitro. Marker Ki67 indicates active
proliferation. (B) Embryonic SSC marker CK5 and basal epithelial marker CK14 colocalized in D7 salispheres. CK5 and CK14 showed partial colocalization
in D14 salispheres. (C) Acinar marker AQP5 was expressed in D7, D14, and D21 salispheres. (D) Acinar marker amylase α was expressed in D7, D14, and D21
salispheres. (E) Luminal epithelial marker CK8 partially colocalized with CK14 in D7 salispheres, but became more concentrated in the center as the spheres
grew (D21). CK14 was highly expressed in the periphery of the salispheres. (F) D7, D14, and D21 salispheres from the third passages of SSCs all expressed SC
markers c-Kit and Sca1. Scale bars: 10 μm (D7); 50 μm (D14); 50 μm (D21).
jci.org   Volume 124   Number 8   August 2014
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Figure 3. SSC transplantation successfully rescues SMG function after irradiation. (A) Experiment schema. (B) Total stimulated saliva secretion measured
before irradiation (basal), 4 weeks after radiation treatment (PRT 4w), and 4, 8 and 12 weeks (PIn 4w, PIn 8w, PIn 12w) after SSC injection in mice receiving
100 SSCs (n = 7), 200 SSCs (n = 8), 300 SSCs (n = 10), 1,000 SSCs (n = 10), 3,000 Lin–CD24+c-Kit–Sca1– cells (n = 10), and 30,000 unsorted bulk submandibular
cells (n = 5). *P < 0.05; **P < 0.01, 1-way ANOVA, compared with Lin–CD24+c-Kit–Sca1– control at the same time point. (C) PAS staining of SMG at 13 weeks
after SSC injection. PAS-positive cells are functional acinar cells. Scale bar: 100 μm. (D) Quantification of the acinar area to total SMG area indicates the
rescue effect of SSC transplantation. **P < 0.01, 1-way ANOVA, compared with Lin–CD24+c-Kit–Sca1– control, n = 10. Data are presented as mean ± SEM.
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Figure 4. SSCs derived from GFP
donor mice proliferate and differentiate in recipient mice. (A)
Representative flow plot of recipient SMG at 13 weeks after GFP+ SSC
injection. GFP donor SSCs differentiated into CD24+ epithelial and CD24lo
cells as well as c-Kit+Sca1+ SSCs.
(B) Quantification of percentage
of GFP+ cells (Lin–GFP+), percentage of GFP+ epithelial cells (Lin–
GFP+CD24+), and percentage of GFP+
SSCs (Lin–GFP+CD24+c-Kit+Sca1+) in
viable cells for the different cohorts
of recipient mice in Figure 3. n = 7,
8, 8, 9, 9, 5 for different cohorts,
respectively. *P < 0.05; **P < 0.01,
1-way ANOVA, compared with 3,000
Lin–CD24+c-Kit–Sca1– control group
cells. Data are presented as mean
± SEM. (C) Immunohistochemical
staining of GFP in SMG transplanted
with 3,000 Lin–CD24+c-Kit–Sca1– cells
or 1,000 SSCs. The magnified views
are showed correspondingly. Arrows
point to secretory ducts, and arrowheads point to acini. Scale bars:
200 μm (left, top two panels);
50 μm (bottom left panel, right
panels); 10 μm (insets). (D) Immunofluorescent staining of GFP and Sca1
(red) in SMG transplanted with 1,000
SSCs. Arrows point to hematopoietic
cells in a blood vessel adjacent to
a duct. These cells are positive for
Sca1 but negative for GFP. Scale bars:
100 μm (upper panels); 10 μm (lower
panels). (E) Immunofluorescent
staining of GFP and CK14 (red) in
SMG transplanted with 1,000 SSCs.
Arrowheads point to GFP and CK14
dual-positive cells located at the
basal layer of the secretory ducts in
SMG. Scale bar: 50 μm.

Injection of as few as 200 Lin–GFP+CD24+c-Kit+Sca1+ SSC–
enriched cells partially rescued saliva secretion at 8 weeks after
transplantation, but the difference did not reach statistical significance. Injection of 300 SSCs significantly improved the saliva
secretion at 8 weeks after transplantation when compared with
the 3,000 Lin–CD24+c-Kit– Sca1– cells injected in mice at the same
time point (P < 0.01). Injection of 1,000 SSCs showed an even
earlier rescue effect seen at 4 weeks after SSC transplantation
(P < 0.05) (Figure 3B). This dose-response relationship, correlating the number of SSCs implanted with improved salivary gland
function, strongly indicates that Lin–GFP+CD24+c-Kit+Sca1+ SSC–
enriched cells were responsible for reconstituting saliva secretion. Based on the flow analysis, the frequency of SSC-enriched

cells in normal murine SMG was around 0.05% (Figure 1C). The
number of SSCs in 30,000 unsorted bulk cells was around 15. The
presence of few SSCs in the unsorted bulk cells likely accounted
for the partial rescue effect noted at 8 to 12 weeks in this group.
There was no rescue of saliva secretion in the Lin–CD24+c-Kit–
Sca1– control group (Figure 3B).
PAS staining, which highlights functional acini, confirmed that
there were more functional acini in SMG transplanted with SSCs
than with the Lin–CD24+c-Kit– Sca1– (Figure 3C and Supplemental
Figure 4). Quantification of intact acinar areas (normalized to total
SMG area) showed approximately 37.6% and 47.5% acini in SMGs
injected with 300 SSCs and 1,000 SSCs, respectively, compared
with 16.1% acini in SMGs injected with Lin–CD24+c-Kit– Sca1– conjci.org   Volume 124   Number 8   August 2014
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Table 1. Short list of genes validated by qPCR
Gene symbol
Ly6d
Wnt10a
Smr3a
Nrxn1
Krt17
Krt14
Il18r1
Ngfr
Krt5
Ly6a(Sca1)
Camk4
Krt15
Fgfr3
Aldh3a1
Gdnf
Wnt6
Krt8
Aqp5

Gene name

GenBank accession no.

Microarray fold change

qPCR fold change

Lymphocyte antigen 6 complex, locus D
Wingless related MMTV integration site 10a
Submaxillary gland androgen regulated protein 3A
Neurexin I
Keratin 17
Keratin 14
IL-18 receptor 1
Nerve growth factor receptor (TNFR superfamily, member 16)
Keratin 5
Lymphocyte antigen 6 complex, locus A
Calcium/calmodulin-dependent protein kinase IV
Keratin 15
FGF receptor 3
Aldehyde dehydrogenase family 3, subfamily A1
Glial cell line–derived neurotrophic factor
Wingless-related MMTV integration site 6
Mus musculus keratin 8 (Krt8), mRNA [NM_031170]
Aquaporin 5

NM_010742
NM_009518
NM_011422
NM_020252
NM_010663
NM_016958
NM_008365
NM_033217
NM_027011
NM_010738
NM_009793
NM_008469
NM_008010
NM_007436
NM_010275
NM_009526
NM_031170
NM_009701

4.50
4.44
4.20
4.10
3.86
3.28
3.28
3.27
3.18
3.01
3.00
2.79
2.70
2.50
2.33
2.14
–0.20
–3.34

5.94
3.4
3.19
2.58
5.62
5.42
5.58
5.19
4.14
2.95
2.93
5.03
3.92
3.75
4.11
1.7
0.57
–1.5

trol cells (P < 0.01) (Figure 3D). Of note, the percentage of intact
acinar in unirradiated SMG ranged from 60% to 70%.
Transplanted SSCs proliferate and differentiate in recipient
murine SMGs. Flow analysis indicated that there were significantly
more Lin–GFP+ cells in the 1,000 SSC-transplanted group compared with the 3,000 Lin–CD24+c-Kit– Sca1– control group (Figure 4,
A and B). GFP+ cells from donor mice successfully differentiated
into Lin–CD24+ cells, Lin–CD24lo cells, and Lin–CD24+c-Kit+Sca1+
cells (Figure 4A). The percentages of Lin–CD24+ epithelial and Lin–
CD24+c-Kit+Sca1+ SSC–enriched cells (in viable cells) were significantly higher in the 1,000 SSC-transplanted group compared with
the control group (Figure 4B).
Immunohistochemical (IHC) staining of GFP further confirmed that there were more GFP+ cells in the 1,000 SSC-transplanted SMG (Figure 4C). Although GFP+ SSCs tended to aggregate around the injection site, we also noted GFP+ cells in regions
distant from the injection site at 12 weeks after transplantation. The
multipotency of the SSCs was proved by the fact that GFP+ SSCs
differentiated into both GFP+ secretory ducts (Figure 4C, arrows)
and GFP+ acini (Figure 4C, arrowheads) at regions near and far
from the transplantation site. These results were further confirmed
by immunofluorescence (IF) staining. A subset of cells expressed
GFP as well as the SC marker Sca1 (Figure 4D) and basal epithelial
marker CK14 (Figure 4E, arrowheads), indicating that some GFP+
cells maintained SSC features and remained undifferentiated at the
basal epithelial layer, where SSCs are normally found. Moreover,
GFP+ SSCs were distinct from endogenous hematopoietic cells,
which were GFP negative but Sca1 positive (Figure 4D, arrow).
GFP+ SSCs isolated from primary recipients successfully rescue
SMG function after radiation in secondary recipients. To confirm
that the Lin–GFP+CD24+c-Kit+Sca1+ SSC–enriched cells could self
renew in vivo after transplantation into recipient SMGs, we performed a serial transplantation study. GFP+ SSCs were isolated
3370
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from the SMGs of the primary recipients and transplanted into
irradiated SMGs of the secondary recipients (Figure 3A). 250 Lin–
GFP+CD24+c-Kit+Sca1+ SSC–enriched cells successfully rescued
saliva secretion in the secondary recipients (Supplemental Figure
5A). Similar to what was found in the primary recipients, Lin–GFP+
cells were able to differentiate into Lin–CD24+, Lin–CD24lo, and
Lin–CD24+c-Kit+Sca1+ SSC–enriched populations (Supplemental
Figure 5B). PAS staining confirmed that SMG morphology was
partially rescued in the secondary recipients (Supplemental Figure 5C). GFP immunolabeling showed that GFP+ SSCs successfully proliferated in the secondary recipients and differentiated
into secretory ducts (Supplemental Figure 5D, arrows) and acini
(Supplemental Figure 5D, arrowheads). CK14 expression likewise
colocalized with GFP in the secretory ducts (Supplemental Figure
5E, arrowheads). Finally, isolated SSCs from secondary recipients
were able to grow into salispheres, which expressed SC marker
Sca1 (Supplemental Figure 5F).
Taken together, these results confirmed that Lin–GFP+CD24+
c-Kit+Sca1+ SSCs were able to self renew in vivo in serial transplantation. The progenies derived from GFP+ SSCs were able to proliferate and differentiate in vivo for at least 6 months after the original isolation. Based on these data, we believe that we have isolated
a relatively pure SSC population for further characterization.
Gene-expression analysis of Lin–CD24+c-Kit+Sca1+ SSC-enriched
population
To investigate the molecular characteristics of SSCs, we performed
gene-expression analysis of a Lin–CD24+c-Kit+Sca1+ SSC–enriched
population compared with Lin–CD24+c-Kit–Sca1– cells using the
Agilent SurePrint G3 Mouse GE microarray platform, which contains 39,430 Entrez Gene RNAs and 16,251 long intergenic noncoding RNAs (lncRNAs). The 197 genes, which showed more than
2-fold elevation in the Lin–CD24+c-Kit+Sca1+ SSC–enriched popula-
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Figure 5. GDNF expression in salispheres and SMG tissues. (A) qPCR showed GDNF mRNA was highly expressed in SSCs compared with Lin–CD24+c-Kit–
Sca1– cells. *P < 0.05, t test. n = 3. Data are presented as mean ± SEM. (B) GDNF colocalized with SC marker c-Kit in the salisphere. Scale bar: 10 μm. (C)
GFRα1 colocalized with basal keratin marker CK14 in the salisphere. Scale bar: 10 μm. (D) GDNF and (E) its receptor GFRα1 were primarily expressed in the
secretory duct of murine SMG by immunohistochemical staining. Scale bars: 100 μm; 50 μm (insets). (F) GDNF signal was elevated 9 weeks after 15-Gy radiation treatment. Scale bar: 50 μm. (G) GDNF colocalized with NCAM in the ducts after irradiation in human SMG (arrows), but not in the neighboring neurons
(arrowheads). (H) GDNF colocalized with pFAK in the ducts after irradiation in human SMG (arrows), but not in the neighboring neurons (arrowheads). (I)
pFAK localized in c-Kit–positive SSCs in the ducts after irradiation in human SMG (arrows). The signals partially overlapped. Scale bar: 10 μm (G–I).

tion, can be categorized into 30 groups through the DAVID Functional Annotation. Growth factors closely regulate SC proliferation,
regeneration, and differentiation. Seven growth factors, Klk1b3,
Klk1b4, Artn, Ptn, Bmp7, Gdnf, and Cxcl12, had elevated expression
in the SSC-enriched population (Supplemental Table 2).
To confirm the gene expression profile of the functional categories with statistical significance, 75 genes were selected for quanti-

tative PCR (qPCR) validation. We focused on the genes in the functional categories of SC markers, epithelial markers, and growth
factors that showed more than 2-fold elevation in the SSC-enriched
population. We also included some genes without any change
(5 genes) or with decreased expression (15 genes) as controls. Out
of 75 genes, 18 were confirmed with qPCR in 4 independent samples (Table 1). As expected, the expression of Sca1 and c-Kit was
jci.org   Volume 124   Number 8   August 2014
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Figure 6. GDNF injection successfully rescues radiation-induced SMG
damage. (A) Treatment with GDNF increased the salisphere number in
SSCs, but not in Lin–CD24+c-Kit–Sca1– cells. (B) Quantification of salisphere
number treated with or without GDNF. **P < 0.01, t test, compared with
nontreated SSCs. SSC (n = 5); Lin–CD24+c-Kit–Sca1– (n = 10). (C) GDNF
increased salisphere count in a dose-dependent manner. **P < 0.01, t test,
compared with nontreated SSCs (n = 6). (D) Experimental schema.
50 μg/mouse GDNF or saline was injected intraglandularly into SMG 1 day
before (E–H) or after (I–K) 15 Gy radiation of the SMG. (E) Total stimulated
saliva secretion measured before irradiation (basal), 1, 2, 3, 4, 6, and 8
weeks after radiation treatment (PRT). n = 10/group. *P < 0.05; **P < 0.01,
t test. (F) PAS staining of SMG 8 weeks after RT. PAS-positive cells are
functional acinar cells. Scale bar: 100 μm. (G) Quantification of the acinar
area to total SMG area indicates the rescue effect of GDNF. **P < 0.01,
t test. (H) Representative flow plot of SMG at 8 weeks after GDNF/saline
injection. Quantification of SSC (Lin–CD24+c-Kit+Sca1+) percentage in viable
cells (DAPI–) indicated that GDNF significantly increased the SSC numbers.
(n = 7/group) **P < 0.01, t test. (I) Total stimulated saliva secretion. GDNF
or Saline was injected 1 day after RT (n = 10/group). *P < 0.05; **P < 0.01,
t test. (J) Quantification of the acinar area to total SMG area. **P < 0.01,
t test. (K) Quantification of SSC percentage in viable cells (n = 8/group).
*P < 0.05, t test. All data are presented as mean ± SEM.

higher in SSC than in control cells. The basal keratin markers Krt5,
Krt15, Krt14 were also highly expressed in SSCs. In contrast, the
expression of differentiation markers Krt8 and Aqp5 were lower in
SSC. The Gene Expression Omnibus (GEO) access for the microarray data can be found on NCBI website (GSE46672).
The role of GDNF in SSCs
GDNF expression in salispheres and SMG tissues. Of interest is GDNF,
which showed a more than 2-fold elevation in SSCs by microarray
and was 4-fold higher in SSCs by qPCR when compared with the
Lin–CD24+c-Kit– Sca1– population (Figure 5A). GDNF preferentially binds to the GDNF family receptor α 1 (GFRα1), which mediates
the activation of the RET receptor tyrosine kinase and functions
through the PI3K/AKT, MEK/ERK and SRC pathways in neurons (33, 34), ureteric buds (35, 36), and spermatogonial SCs (37).
Recent studies indicated that the neural cell adhesion molecule
(NCAM) and the downstream targets FYN/FAK may function as
alternative pathways for GDNF in regulating axonal guidance and
corneal regeneration (38–41).
In cultured salispheres, GDNF expression colocalized with
the SC marker c-Kit (Figure 5B), while GFRα1 colocalized with the
basal keratin marker CK14 (Figure 5C). In murine SMG tissues,
GDNF (Figure 5D, arrows) and GFRα1 (Figure 5E) were located at
the basal layer of the secretory duct epithelium. Similar localization was also noted in human SMG (Supplemental Figure 6, A and
B). Moreover, GDNF expression overlapped with that of GFRα1 in
mouse SMG (Supplemental Figure 6C). The expression of RET, a
receptor tyrosine kinase that can be activated upon GDNF’s binding to GFRα1, was relatively weak and did not show enrichment in
the ducts (Supplemental Figure 6D). The signal of NCAM, another
coreceptor, was too weak to be detected in normal SMG tissues.
In irradiated murine and human SMGs, GDNF expression
was highly upregulated (Figure 5F and Supplemental Figure 6E).
The coreceptor NCAM became detectable after RT and colocalized with GDNF in the secretary duct (Figure 5G, arrows), but not
in the neighboring neurons (Figure 5G, arrowheads). Moreover,
phosphor-FAK (pFAK), the downstream target of NCAM, was also
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detected in the ducts and colocalized with both GDNF (Figure 5H,
arrows) and c-Kit (Figure 5I, arrows) in irradiated SMG tissues. In
contrast, the downstream target of RET, including phosphor-AKT
(pAKT) (Supplemental Figure 6F) and phosphor-ERK (pERK)
(Supplemental Figure 6G) did not colocalize with c-Kit in irradiated SMG tissues. These results indicated that in SSCs, GDNF
and GFRα1 were likely to function through the interaction with
the coreceptor NCAM, which then activated FAK after radiation
damage to the SMG.
GDNF promotes salisphere growth in vitro. To further evaluate
the role of GDNF in SSCs, we applied GDNF in vitro on SSCs. When
GDNF (100 ng/ml) was added to SSCs in culture, it significantly
increased salisphere-forming cell frequency, from 2.7% to 4.0%,
whereas it had no effect on control Lin–CD24+c-Kit–Sca1– cells (Figure 6, A and B). In addition, GDNF increased the salisphere number in a dose-dependent manner (Figure 6C). These data suggest
that GDNF is a potential growth factor to promote SSC survival.
GDNF successfully rescues SMG after radiation. We investigated
whether GDNF treatment in vivo would improve saliva production in irradiated SMGs. A single dose of 50 μg GDNF was injected
directly into the SMG of each mouse 24 hours before 15-Gy irradiation. Saliva secretion was measured up to 8 weeks after RT, at the
time of sacrifice (Figure 6D). When compared with control saline
injection, a single GDNF injection significantly improved saliva
production in irradiated mice. The rescue effect was durable, up to
8 weeks after irradiation, when the mice were euthanized for histological studies (Figure 6E). There was no difference in the body
weights of GDNF and saline-injected mice, suggesting no systemic
toxicity. PAS staining revealed more functional and intact acini in
GDNF-treated SMGs than in saline glands (Figure 6F), translating
to a larger area of intact acini in GDNF-treated mice (Figure 6G).
FACS studies also showed significantly more SSCs in GDNF-treated SMGs compared with saline-treated controls (Figure 6H).
Since GDNF expression is elevated after RT, we also tested
whether GDNF injection after RT would rescue the saliva production (Figure 6D). 50 μg GDNF was injected directly into the SMG
of each mouse 24 hours after 15 Gy irradiation. GDNF improved
saliva production after RT (Figure 6I) and increased the percentage of functional acini (Figure 6J and Supplemental Figure 7A).
FACS studies again showed more SSCs in GDNF-treated SMG
than the saline group (Figure 6K and Supplemental Figure 7B).
GDNF does not function as a radio protector in SMG. To rule out
the possibility that GDNF acted as a general radiation protector of
mature salivary cells, we investigated whether GDNF could protect rat SMG cell line SMG-C6 from radiation-induced cell damage. Clonogenic survival assay showed that GDNF treatment did
not affect cell survival from radiation treatment (Supplemental
Figure 8A). ROS generated during irradiation as a result of water
radiolysis was not changed by GDNF treatment (Supplemental Figure 8B). The pattern of phosphor-γH2AX after irradiation
over time, which reflected radiation-induced DNA double-strand
breaks, was not different with or without GDNF treatment (Supplemental Figure 8C). Although RT induced a G1 arrest in SMG-C6
cells, there was no difference in the cell-cycle pattern with or without GDNF treatment (Supplemental Figure 8D). These data all
indicated that GDNF did not act as an overall radio protector in
mature salivary cells.
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GDNF treatment did not accelerate HNC growth. In HNC cell
line SCC 22A, 100 ng/ml GDNF applied 30 minutes before RT
did not affect clonogenic survival (Supplemental Figure 9A). More
importantly, intratumor injection of 50 μg GDNF 24 hours after
12-Gy irradiation to the tumor did not affect the tumor growth
delay compared with the control (Supplemental Figure 9B).
These data indicated that GDNF did not modify tumor growth or
response to irradiation.

Discussion

Repair and reconstitution of adult tissues depends on a small population of SCs. Adult SCs are believed to be quiescent, but become
activated and drive tissue regeneration upon damage (10, 42, 43).
There is an increasing interest in SC therapy to restore salivary
gland function after radiation. SCs from tissues other than salivary
gland, including bone marrow (7, 44–50), pancreas (51), and lacrimal gland (52), have been shown to differentiate into salivary acinar–like structures in vitro, but whether these cells can have acini
function in vivo remains to be further investigated.
SCs that reside in the salivary microenvironment are programmed to differentiate into adult glands and are more likely to
form functional subunits than SCs from other organs. Recently,
efforts have been made to isolate a pure population of adult SSCs.
Several single cell-surface markers, including c-Kit (5), Sca1 (5, 7),
Thy-1 (8), integrin α6β1 (9, 10), and CD34 (11), have been used to
identify these cells. Although these subpopulations exhibited
certain SC properties in vitro, only c-Kit–positive cells have been
transplanted in vivo and could partially rescue saliva function.
Identification of a pure SSC population will help to reduce the
number of SSCs required for future therapy and will allow for better characterization of these cells.
Here, by using multiple cell-surface markers, we have identified a highly enriched population of SSCs, as demonstrated by
their ability to form more spheres and rescue salivary function
after irradiation in vivo with relatively few cells. More importantly, these Lin–CD24+c-Kit+Sca1+ cells can differentiate into duct and
acinar structures, demonstrating multipotency and self-renewal
ability both in vitro and in vivo through serial transplantation studies, up to 6 months after initial isolation.
Several pathways have been implicated in SSC regeneration, proliferation, and differentiation. These include the WNT
and NOTCH signaling pathways for SC self renewal and lineage
determination (53–56), ASCL3 for proliferation (57), and GSK3β
for cell differentiation (58). In addition, the SC niche clearly plays
an important role in the fate of SCs (59). Many growth factors
are involved in salivary gland morphogenesis during development and regeneration (60), including keratinocyte growth factor
(KGF, also known as FGF7) (61), FGF10 (62–64), and EGFR (65).
Our gene-expression analysis of the Lin–CD24+c-Kit+Sca1+ SSC–
enriched population confirmed that several of the genes involved
in SC self renewal, lineage determination, and development are
differentially upregulated in these cells. These genes include Wnt
members Wnt10a and Wnt6, which are involved in osteogenesis
through a β-catenin–dependent mechanism (66). Wnt6 was also
implicated in inducing epithelialization of primitive endodermal
cells (67). Nerve growth factor receptor (NGFR, also known as p75
and CD271), has been identified as a stem SC marker in neuron
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(68), bone marrow (69), and adipose tissue (70). The keratin SC
markers CK5 and CK14, which are important in maintaining epithelial proliferation (71), are highly expressed in SSCs. Keratin 15
a SC marker in the hair follicle (72), and keratin 17 could compensate for the loss of CK14 in mouse keratinocytes in maintaining
cell growth (73). The role of these SSC-enriched genes in SC function will need further investigation.
Of interest are genes that have not been previously identified in SSC self renewal. One such genes is Gdnf, which is highly
expressed in the SSC-enriched population compared with other
epithelial cells. GDNF is known to play an important role in neuron survival, growth, differentiation, and migration (13, 14) and
has been implicated in renal morphogenesis and spermatogenesis
by promoting SC self renewal and proliferation (15–17). Recently,
a GDNF family member, NRTN, was reported to promote mouse
embryonic SMG regeneration (74). Our data showed that GDNF
treatment resulted in enhanced SSC survival and mitigation of RTinduced functional damage in vivo. Injection of a single dose of
50 μg GDNF into the SMG either before or after RT significantly
improved saliva secretion in irradiated mice. The functional rescue was associated with a higher SSC yield in vivo when compared
with saline controls. GDNF also promoted salisphere formation
of SSCs in vitro in a dose-dependent manner, but did not protect
differentiated acinar cells from RT damage. Our findings strongly
support that GDNF did not function as a general radiation protector, but rather promoted regeneration through SSCs.
GDNF binds to GFRα1, which mediates the activation of
either the RET receptor tyrosine kinase or the NCAM in neurons.
RET activates the PI3K/AKT, MEK/ERK, and SRC pathways, and
NCAM activates the FYN/FAK pathway. Through these downstream targets, GDNF prevents apoptosis and promotes proliferation and differentiation in neurons (33, 34, 38–40), ureteric
bud (35, 36), and spermatogonial SCs (37). Our results show that
GDNF and its receptor, GFRα1, are found primarily in SSCs, suggesting that GDNF mainly acts as an autocrine factor. The fact that
radiation increased the expression of GDNF and its colocalization
with NCAM and pFAK in ductal epithelium suggests that GDNF
activates the NCAM/FAK pathway in SSCs after RT damage.
ETS transcription factors ETV4 and ETV5 are known downstream targets of the GDNF/RET pathway and are involved in
neuronal development (75), kidney branching (76), and spermatogenesis (77). In our microarray analysis, Etv4 and Etv5 were not
upregulated in the SSCs, but 2 other ETV family transcription factors, Etv6 and Etv1, were found enriched in SSCs. However, neither
Etv6 nor Etv1 expression showed significant changes in SSCs upon
GDNF treatment. These data, coupled with the fact that GDNF did
not colocalize with RET, pAKT, or pERK in either salispheres or
salivary ductal cells, suggest that the RET signaling pathway may
not be a significant player in the GDNF pathway in SSC.
Since GDNF is currently being evaluated for the treatment of
human Parkinson disease in clinical trials (18, 19). The potential
application of GDNF in improving the survival of SCCs would be
readily translated to the clinic. Although our results showed that
GDNF was not a general radiation protector for mature salivary
cells, whether GDNF primarily promotes SSC survival and proliferation after radiation or can also promote SSC differentiation remains
to be further investigated. We have shown that GDNF treatment did
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not affect radiation response or tumor growth in an HNC cell line.
However, since GDNF is a growth factor, its effect on promotion of
salivary cancer development will need to be thoroughly studied.
In summary, we have identified a relatively pure SSC population that is capable of self renewal and functional restoration of
irradiated SMG. We have also identified a growth factor, GDNF,
that appears to increase the SSC population after radiation treatment and did not promote tumor growth in a HNC cell line. Manipulation of the GDNF pathway may provide a promising avenue for
future SSC therapy in the clinical setting.

Methods

Animals. C57BL/6 mice and C57BL/6-Tg(UBC-GFP)30Scha/J mice
were purchased from Jackson Laboratory.
Flow cytometry. SMG tissues were minced and dissociated in
DMEM/F12 medium (Gibco; Invitrogen) containing collagenase I
(0.025%), hyaluronidase (0.04%), CaCl2 (6.25 mM), and 25 U/ml dispase (BD Biosciences) for 2 hours at 37°C. The dissociated cells were
centrifuged at 300 g and filtered through a 400 μm Millipore filter (Millipore). After the red blood cell lysis, primary SMG cells were incubated
simultaneously with anti-mouse CD24, CD45, CD31, Sca1 (eBioscience), and c-Kit antibodies (BD Biosciences) for 30 minutes on ice to
determine the SC population. Cell viability was detected with DAPI
(Invitrogen). Cells were sorted on a BD FACS Aria II (BD Biosciences).
Irradiation and intraglandular injection. Six- to eight-week-old
female C57BL/6 mice were exposed to a single dose of 15 Gy ionized
irradiation (250k Vp orthovoltage) using the IC-225 Specimen Irradiation System (Kimtron Medical). The SMGs were irradiated from
the lateral side (7.5 Gy per side, total 15 Gy), with the rest of the body
protected by a lead shield, as previously reported (11). Representative
photographs of the procedure are shown in Supplemental Figure 10. In
brief, 4 weeks after irradiation, mice were anesthetized and SMG was
exposed by small incision. Sorted cells were suspended in 10 μl culture
medium with 0.5% trypan blue. 5 μl of cells were injected into each side
of the SMGs using a 10 μl microinjection syringe (Hamilton Co.). The
skin incision was closed with surgical suture. Then 50 μg/mouse GDNF
(R&D Systems) was injected through open surgery as described about.
Saliva collection. Saliva was collected for 15 minutes after 2 mg/kg
pilocarpine injection (s.c.), as previously described (11). The saliva
flow rate was determined at basal condition, 4 weeks after radiation
(postradiation treatment [PRT] 4w), and 4, 8, and 12 weeks after cell
injection (postinjection [PIn] 4w, PIn 8w, and PIn 12w). The measured
saliva secretion was normalized to the mouse body weight, assuming
1 g/ml density for saliva.
Microarray and analysis. Total RNA from the sorted cells was
extracted with RNeasy kit (QIAGEN) following the manufacturer’s
protocols. Gene expression was determined with Agilent SurePrint G3
Mouse GE 8x60K arrays (Agilent Technologies) at Stanford Functional Genomics Facility and analyzed with GeneSpringGX (Agilent Technologies). The signal threshold intensity was greater than 5, baseline
1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics,
2010. CA Cancer J Clin. 2010;60(5):277–300.
2. Cotrim AP, et al. Kinetics of tempol for prevention of xerostomia following head and neck
irradiation in a mouse model. Clin Cancer Res.
2005;11(20):7564–7568.

transformation was made to the median of all samples and normalized
to the 75th percentile shift. Genes showing more than 2-fold elevation
compared with control were further categorized through the DAVID
Functional Annotation Tool (http://david.abcc.ncifcrf.gov/) following
instructions. The GEO accession number for microarray data reported
in this paper is GSE46672.
Salisphere and cell culture. Sorted cells were suspended in DMEM/
F12 medium supplemented with 10% FBS, N2, B27, EGF (20 ng/ml),
FGF2 (10 ng/ml) and IGF-1 (50 ng/ml), penicillin (100 U/ml), and
streptomycin (100 mg/ml) (Gibco; Invitrogen), and then plated on
Matrigel (BD Biosciences) in 96-well plates. Medium change was
performed every other day. Salisphere numbers were counted on D7
and D14 of culture.
For in vitro passaging, D7 salispheres were released from Matrigel by Dispase (BD Biosciences) treatment for 30 minutes at 37°C,
followed by 0.25% trypsin/EDTA for 3 minutes at 37°C, then passing through a 25-gauge needle 3 to 5 times. Single cells were counted
under microscope and then plated again on a Matrigel 96-well plate.
Rat submandibular epithelial cell line SMG-C6 was obtained from
Robert Castro (Neonatal and Developmental Medicine, Stanford University) and Margarita M. Vasquez (Neonatal Medicine, University of
Texas Health Science Center, San Antonio, Texas, USA). Cells were
cultured in DMEM/F12 medium as previously reported (78).
For additional information, see Supplemental Methods.
Statistics. Data were expressed as SEM. Statistical ANOVA and
Student’s t tests (2-tailed) were use to compare the data. P ≤ 0.05 is
considered to be significant.
Study approval. All animal procedures were approved by the Institutional Animal Care and Use Committee at Stanford University.
Patient samples were collected via a protocol approved by the Stanford
Institutional Review Board (IRB #17757).
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